Drug Trial Radar · NCT00724126
Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)
Last checked: Nov 20, 2026Latest source record: Nov 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
637
Actual
Start
Jul 2008
Primary completion
Aug 2009
Study completion Sep 2009
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 29, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy of a 14-day course of rifaximin given 3 times a day vs. placebo in providing adequate relief of IBS symptoms.
Conditions
- Non-Constipation Irritable Bowel Syndrome
Interventions
RifaximinDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects Who Had Adequate Relief of Global IBS Symptoms for at Least 2 of the 4 Weeks During the Primary Evaluation Period (ie, Weeks 3 Through 6).Time frame: 4 weeks
Locations
88 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Anniston, Alabama
Site not named
Birmingham, Alabama
Site not named
Huntsville, Alabama
Site not named
Tempe, Arizona
Site not named
Anaheim, California
Site not named
Carmichael, California
Site not named
Chula Vista, California
Site not named
Concord, California
Site not named
Garden Grove, California
Site not named
Laguna Hills, California
Site not named
Lakewood, California
Site not named
Los Angeles, California
Site not named
Monterey, California
Site not named
Orange, California
Site not named
Roseville, California
Site not named
San Carlos, California
Site not named
San Francisco, California
Site not named
Bristol, Connecticut
Site not named
Hamden, Connecticut
Site not named
Newark, Delaware
Site not named
Boca Raton, Florida
Site not named
Hollywood, Florida
Site not named
Largo, Florida
Site not named
New Port Richey, Florida
Site not named
New Smyrna Beach, Florida
Site not named
Port Orange, Florida
Site not named
St. Petersburg, Florida
Site not named
Tampa, Florida
Site not named
Zephyrhills, Florida
Site not named
Atlanta, Georgia
Site not named
Macon, Georgia
Site not named
Elkhart, Indiana
Site not named
Kansas City, Kansas
Site not named
Topeka, Kansas
Site not named
Bowling Green, Kentucky
Site not named
Metairie, Louisiana
Site not named
Monroe, Louisiana
Site not named
Baltimore, Maryland
Site not named
Elkridge, Maryland
Site not named
Wellesley, Massachusetts
Showing 40 of 88 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.